William Blair Weighs in on Avantor's Q1 Earnings (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR - Free Report) - Analysts at William Blair cut their Q1 2025 earnings estimates for shares of Avantor in a note issued to investors on Monday, October 28th. William Blair analyst M. Larew now forecasts that the company will post earnings of $0.25 per share for the quarter, down from their previous forecast of $0.29. The consensus estimate for Avantor's current full-year earnings is $1.01 per share. William Blair also issued estimates for Avantor's Q2 2025 earnings at $0.30 EPS and FY2025 earnings at $1.18 EPS.

A number of other analysts have also recently issued reports on the company. Morgan Stanley increased their target price on Avantor from $28.00 to $29.00 and gave the stock an "overweight" rating in a research note on Monday, July 29th. Wells Fargo & Company cut their price objective on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday. TD Cowen increased their target price on Avantor from $28.00 to $31.00 and gave the stock a "buy" rating in a report on Monday, July 29th. Robert W. Baird reduced their price objective on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research report on Monday. Finally, Barclays dropped their target price on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.

Avantor Trading Down 0.6 %

Shares of NYSE:AVTR traded down $0.13 during midday trading on Wednesday, hitting $22.39. The company had a trading volume of 1,759,799 shares, compared to its average volume of 6,407,948. The firm has a fifty day simple moving average of $25.38 and a 200 day simple moving average of $24.22. The stock has a market cap of $15.21 billion, a price-to-earnings ratio of 57.74, a PEG ratio of 2.93 and a beta of 1.33. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. Avantor has a 12 month low of $17.06 and a 12 month high of $28.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Versant Capital Management Inc boosted its holdings in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. grew its holdings in Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock valued at $31,000 after buying an additional 1,391 shares in the last quarter. UMB Bank n.a. bought a new stake in shares of Avantor during the third quarter valued at about $49,000. Nisa Investment Advisors LLC lifted its holdings in shares of Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock worth $53,000 after buying an additional 835 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock valued at $70,000 after acquiring an additional 1,285 shares during the period. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the company's stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.50% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.